Liu, Guangwen
Xue, Jinling
Wang, Yanli
Liu, Zhengzhi
Li, Xue
Qu, Dongmei
Su, Zhengjie
Xu, Kaibo
Qu, Xinyao
Qu, Zhaojuan
Sun, Linlin
Cao, Mingming
Wang, Ying
Chen, Xuesong
Yu, Jing
Liu, Lang
Deng, Qiaohuan
Zhao, Yicheng
Zhang, Lixiu
Yang, Haimiao
Funding for this research was provided by:
Chia Tai Tianqing Pharmaceutical Group Co.,Ltd (phase I 2017-041, phase I 2017-041, phase I 2017-041, phase I 2017-041, phase I 2017-041, phase I 2017-041, phase I 2017-041, phase I 2017-041, phase I 2017-041, phase I 2017-041, phase I 2017-041, phase I 2017-041, phase I 2017-041, phase I 2017-041, phase I 2017-041, phase I 2017-041, phase I 2017-041, phase I 2017-041, phase I 2017-041)
Article History
Received: 28 April 2022
Accepted: 13 June 2022
First Online: 30 June 2022
Declarations
:
: All data related to this study were interpreted by the trial staff with complete independence from the sponsor. Jinling Xue and Li Xue are employees of Chia Tai Tianqing Pharmaceutical Group Co.,Ltd; Guangwen Liu, Yanli Wang, Zhengzhi Liu, Xinyao Qu, Zhaojing Qu, Linlin Sun, Mingming Cao, Ying Wang, Lixiu, Zhang, Haimiao Yang are employees of Affiliated Hospital of Changchun University of Chinese Medicine. Qiaohuan Deng, Zhengjie Su and Kaibo Xu are graduate students of Affiliated Hospital of Changchun University of Chinese Medicine. Xuesong Chen, Jing Yu, Dongmei Qu, Lang Liu are employees of Ansiterui Medical Technology Consulting Co.,Ltd. Jilin, China. Yicheng Zhao is an employee of Puheng Technology Co., Ltd. The authors have no other relevant affiliations or financial involvement with any organization or entity with financial interest in or financial with the subject matter or materials discussed in the manuscript apart from those disclosed.